We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




MiRNA Microarray Offers Wider Range with Greater Sensitivity

By LabMedica International staff writers
Posted on 15 Mar 2011
Projects aimed at the development of procedures for personalized medicine as well as other biotechnology research will be able to take advantage of a new generation of microRNA (miRNA) microarrays.

The new "GeneChip miRNA 2.0 Array” is produced by Affymetrix, Inc. More...
(Santa Clara, CA, USA). It is an enhanced version of Affymetrix's highly regarded miRNA view system.

The GeneChip miRNA 2.0 Array offers the broadest coverage of known miRNA, encompassing 131 organisms on a single array, and nearly doubles the content of the previous array. Moreover, it is the only array that contains unique probe sequences designed to independently interrogate human, mouse, and rat precursor RNA (pre-miRNA) and mature miRNA in the same experiment.

The GeneChip miRNA 2.0 Array has excellent sensitivity across every miRNA transcript. Testing has demonstrated that the array could reproducibly detect 94% of all transcripts present in a 1.0 amol [10-18 mol] sample. Coupled with the Genisphere FlashTag Biotin RNA Labeling Kit, the new array maintains the same assay protocol, requiring only a 45-minute assay with no amplification or purification steps, and as little as 100 ng of input total RNA.

"This new GeneChip miRNA 2.0 Array demonstrates Affymetrix' commitment to stay at the forefront of gene expression analysis and to provide life scientists with relevant and timely content that is critical to research in gene expression and cellular function,” said Dr. Kevin Cannon, vice president of expression applications at Affymetrix. "With its complete and comprehensive view of all coding and noncoding miRNA, researchers gain greater access to the entire miRNA spectrum--from human to model organisms, at a competitive price.”


Related Links:
Affymetrix, Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Portable POCT Blood Gas Analyzer
BD100
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.